National Institute of Pharmaceutical Education and Research Hyderabad

What is the placement record at National Institute of Pharmaceutical Education and Research Hyderabad?

National Institute of Pharmaceutical Education and Research Hyderabad placed 90.48% of its eligible PG students in the 2026 placement cycle, with a highest package of ₹40 LPA (₹40,00,000) and a median package of ₹6.68 LPA as per the NIRF 2026 report. In concrete terms, 171 of 189 registered students secured offers, while NIPER Hyderabad does not publish a separate mean/average figure, instead reporting the median as its headline number. This places NIPER Hyderabad among the most consistently placed government pharmacy institutes in India, backed by its NIRF 2025 rank of 5th in the Pharmacy category with a score of 75.64. The institute is an Institute of National Importance under the Department of Pharmaceuticals, and its two-year PG programmes (M.Pharm, M.Tech and MBA Pharm) feed directly into the pharmaceutical and life-sciences industry clustered around Hyderabad's Genome Valley.

The pattern at NIPER Hyderabad is one of high placement consistency rather than headline-chasing salaries: placement rates have sat above 90% for three straight cycles, while the median package reflects entry-level R&D, formulation and regulatory-affairs roles in the pharma sector. The ₹40 LPA peak in 2026 is an outlier driven by a small number of premium offers, so applicants should treat the median, not the maximum, as the realistic benchmark.

Year-Wise Placement Statistics

The table below tracks NIPER Hyderabad's placement performance across the 2026, 2024 and 2023 cycles using figures drawn from the institute's NIRF disclosures and placement cell. It answers the core question every aspirant asks: how many students actually get placed each year, and at what salary level. Read the "% Placed" column as the share of eligible registered students who received offers, and the "Median Package" column as the official central salary (NIPER Hyderabad publishes the median rather than a simple average). Where a separate highest or average figure was not officially disclosed for a given year, the cell is marked "Not disclosed".

The takeaway for an applicant is stability: NIPER Hyderabad has placed more than 90% of eligible students in both 2026 (90.48%) and 2024 (92.18%), so the dip from 92.18% to 90.48% is marginal and reflects a larger eligible cohort (189 students in 2026 versus 179 in 2024), not a weakening market. The median, meanwhile, has crept upward from ₹6.00 LPA in 2023 to ₹6.20 LPA in 2024 and ₹6.68 LPA in 2026, signalling steady, if modest, salary growth for the typical graduate.

Top Recruiters at National Institute of Pharmaceutical Education and Research Hyderabad

NIPER Hyderabad's recruiter base is dominated by India's largest pharmaceutical manufacturers and contract-research organisations, many headquartered in or around Hyderabad. The institute's placement cell reports that recruiters span drug discovery, formulation, manufacturing, regulatory affairs and pharma-IT. Below are verifiable recruiters grouped by sector; the concentration of Hyderabad-based pharma majors is a direct advantage of the institute's location in the city's life-sciences corridor.

Pharmaceutical and life-sciences companies

Dr Reddy's Laboratories, Aurobindo Pharma, Hetero Drugs, Neuland Laboratories, Biological E Limited, Torrent Pharmaceuticals, Sun Pharma, Lupin, Natco Pharmaceuticals, Suven Life Sciences, Aizant, Allergan India, Pfizer, Novartis, AstraZeneca and Biocon recruit across R&D, formulation development, analytical and quality roles.

Pharma-services, IT and healthcare analytics

TCS, WNS India and Indegene hire NIPER Hyderabad graduates into regulatory affairs, pharmacovigilance, medical writing and healthcare-analytics functions. This services layer is increasingly important for M.Pharm (Pharmacoinformatics) and MBA Pharm students seeking non-bench roles.

The takeaway is that NIPER Hyderabad graduates are recruited overwhelmingly by domain employers rather than generalist firms, which keeps placement rates high but anchors median salaries to pharma-sector entry pay. Students aiming for the ₹40 LPA tier typically target the analytics, regulatory or product-management roles offered by the services and multinational recruiters rather than core bench R&D.

Sector & Role-Wise Breakdown

NIPER Hyderabad does not publish an official sector-by-sector share-of-offers table, so the breakdown below is an indicative grouping of where its PG graduates are absorbed, based on the recruiter mix and the institute's programme structure. The dominant destination is the core pharmaceutical industry; treat the package ranges as orientation around the verified ₹6.68 LPA median (2026) and the ₹40 LPA ceiling, not as guaranteed figures.

The pattern is clear: the bulk of NIPER Hyderabad offers cluster around the institute's ₹6.68 LPA median in core pharma functions, while the highest packages of up to ₹40 LPA come from a narrow band of analytics, consulting and multinational roles. For an applicant, this means the median is the honest expectation for a typical M.Pharm graduate, and the headline maximum is achievable only for a select few with the right specialisation and profile.

Placement Trend Analysis

The trajectory at NIPER Hyderabad over the last four reported cycles is one of broadening intake with stable-to-rising outcomes. The number of students placed has grown steadily from 142 in 2022 and 155 in 2023 to 165 in 2024 and 171 in 2026, while the placement percentage has held above 90% in the most recent cycles (92.18% in 2024 and 90.48% in 2026). The slight percentage dip in 2026 is explained by a larger eligible pool (189 students versus 179 the year before) rather than fewer offers, since the absolute count of placed students actually rose.

On salaries, the median has trended upward from ₹6.00 LPA (2023) to ₹6.20 LPA (2024) and ₹6.68 LPA (2026), a roughly 11% rise over the period that tracks general pharma-sector wage growth. The one anomaly is 2022, when NIRF data recorded a higher median of ₹8.85 LPA for a smaller cohort of 142 placed students, suggesting that year's graduating batch skewed toward higher-paying roles; the subsequent settling around ₹6 LPplus reflects a normalised, larger intake. The ₹40 LPA highest package in 2026 confirms that premium offers remain available at the top end. The overall read for an applicant: NIPER Hyderabad offers near-certain placement (above 90%) at a dependable mid-six-figure median, with strong upside only for specialised, industry-ready profiles.